Fossom L - Search Results

1

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Laughren TP, Gobburu J, Temple RJ, Unger EF, Bhattaram A, Dinh PV, Fossom L, Hung HM, Klimek V, Lee JE, Levin RL, Lindberg CY, Mathis M, Rosloff BN, Wang SJ, Wang Y, Yang P, Yu B, Zhang H, Zhang L, Zineh I. Laughren TP, et al. Among authors: fossom l. J Clin Psychiatry. 2011 Sep;72(9):1166-73. doi: 10.4088/JCP.11r06984. J Clin Psychiatry. 2011. PMID: 21951984 Review.

2

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.

Zhang J, Mathis MV, Sellers JW, Kordzakhia G, Jackson AJ, Dow A, Yang P, Fossom L, Zhu H, Patel H, Unger EF, Temple RJ. Zhang J, et al. Among authors: fossom l. J Clin Psychiatry. 2015 Jan;76(1):8-14. doi: 10.4088/JCP.14r09164. J Clin Psychiatry. 2015. PMID: 25562777

3

Genotoxicity of 2-bromo-3'-chloropropiophenone.

Meng F, Yan J, Li Y, Fu PP, Fossom LH, Sood RK, Mans DJ, Chu PI, Moore MM, Chen T. Meng F, et al. Among authors: fossom lh. Toxicol Appl Pharmacol. 2013 Jul 15;270(2):158-63. doi: 10.1016/j.taap.2013.04.012. Epub 2013 Apr 26. Toxicol Appl Pharmacol. 2013. PMID: 23628427

4

ANX7, a candidate tumor suppressor gene for prostate cancer.

Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M, Leighton X, Fehrle W, Pittaluga S, Raffeld M, Koivisto P, Willi N, Gasser TC, Kononen J, Sauter G, Kallioniemi OP, Srivastava S, Pollard HB. Srivastava M, et al. Among authors: fossom l. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4575-80. doi: 10.1073/pnas.071055798. Epub 2001 Apr 3. Proc Natl Acad Sci U S A. 2001. PMID: 11287641 Free PMC article.

5

LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Koustova E, Sei Y, Fossom L, Wei ML, Usherwood PN, Keele NB, Rogawski MA, Basile AS. Koustova E, et al. Among authors: fossom l. J Clin Invest. 2001 Mar;107(6):737-44. doi: 10.1172/JCI11500. J Clin Invest. 2001. PMID: 11254673 Free PMC article.

6

Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.

Nahum-Levy R, Fossom LH, Skolnick P, Benveniste M. Nahum-Levy R, et al. Among authors: fossom lh. Mol Pharmacol. 1999 Dec;56(6):1207-18. doi: 10.1124/mol.56.6.1207. Mol Pharmacol. 1999. PMID: 10570048

7

Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons.

Lin Y, Fossom LH, Skolnick P, Long JB. Lin Y, et al. Among authors: fossom lh. Eur J Pharmacol. 1998 Sep 4;356(2-3):255-60. doi: 10.1016/s0014-2999(98)00515-9. Eur J Pharmacol. 1998. PMID: 9774257

8

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

Boyer PA, Skolnick P, Fossom LH. Boyer PA, et al. Among authors: fossom lh. J Mol Neurosci. 1998 Jun;10(3):219-33. doi: 10.1007/BF02761776. J Mol Neurosci. 1998. PMID: 9770644

9

Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.

Viu E, Zapata A, Capdevila JL, Fossom LH, Skolnick P, Trullas R. Viu E, et al. Among authors: fossom lh. J Pharmacol Exp Ther. 1998 May;285(2):527-32. J Pharmacol Exp Ther. 1998. PMID: 9580593

10

Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis.

Sei Y, Fossom L, Goping G, Skolnick P, Basile AS. Sei Y, et al. Among authors: fossom l. Neurosci Lett. 1998 Jan 30;241(2-3):180-4. doi: 10.1016/s0304-3940(97)00980-4. Neurosci Lett. 1998. PMID: 9507950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page